: Which of the following are the 3 MOST important to look at when considering our inclusion/exclusion criteria? View
: Which of the following are described as the key objectives of a Phase I trial, regardless of drug? View
: You have developed inclusion/exclusion (I/E) criteria for a clinical study. Subject enrollment is slow. Based on regulatory guidelines, are you allowed to revise I/E criteria during the course of the study? View
Admin